Dr. Daniel T. Jones is an Internal Medicine Resident Physician and Hematology and Oncology Researcher with a focus on early-phase (Phase I) clinical trials and oncology drug development. His research integrates artificial intelligence and computational biology, particularly AlphaFold-based protein structure prediction, to accelerate target discovery and precision therapeutic design in cancer. Dr. Jones’s work spans translational oncology, safety profiling in targeted therapies, and the application of AI-driven modeling to identify actionable targets across tumor types. His long-term goal is to establish a dedicated drug development and Phase I clinical trial enterprise that leverages AI, molecular modeling, and precision medicine principles to streamline first-in-human oncology trials and bring novel therapeutics to patients more efficiently. He is currently pursuing an MBA at Johns Hopkins University with a concentration in innovation, healthcare management, and strategic commercialization in oncology.
MountainView Hospital
Las Vegas, Nevada, USA